Respicardia, Inc.

Respicardia, Inc.

Respicardia, Inc.

Respicardia develops implantable therapies to improve respiratory andcardiovascular health.
Type
B2c
Founded
2006
Raised
$7.1M
Follow us
Alexa global traffic share
Latest funding
$5,100,000
Debt financing - 2017
Sorin Group
$2,003,994
Convertible Note - 2014
Team Size
1–10
Employees
$5,100,000 Debt financing
Twin Cities Business

Respicardia Raises $5.1M After Positive Results in Sleep Apnea Trial